Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7176 - 7200 of 7847 in total

Methanesulfonyl Fluoride

Methanesulfonyl Fluoride has been used in trials studying the treatment of Safety.
Investigational

Prednimustine

Prednimustine has been used in trials studying the treatment of Lymphoma.
Investigational

Dansylamide

Experimental

Sulfadicramide

Experimental

1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea

Experimental

(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE

Experimental

N-(1,4-dihydro-5H-tetrazol-5-ylidene)-9-oxo-9H-xanthene-2-sulfonamide

Experimental

1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM

Experimental

Glufosfamide

Investigational

3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one

Experimental

(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE

Experimental

5-(2-methylpiperazine-1-sulfonyl)isoquinoline

Experimental

[Methylseleno]Acetate

Experimental

Aconitate Ion

Experimental

5-hydroxynaphthalene-1-sulfonamide

Experimental

Flufenoxuron

Flufenoxuron is under investigation in clinical trial NCT00922870 (Evaluation of Hemodynamic Effects of Cascade Hemofiltration in Septic Shock).
Investigational

3,5-Difluorobenzenesulfonamide

Experimental

ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE

Experimental

2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide

Experimental

Nicotinamide adenine dinucleotide cyclohexanone

Experimental

Navitoclax

Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies, among others. Navitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of...
Investigational

DODECANESULFONATE ION

Experimental

Ethoxzolamide

Ethoxzolamide is a sulfonamide used as diuretic and in glaucoma. It inhibits carbonic anhydrase activity in proximal renal tubules to decrease reabsorption of water, sodium, potassium, bicarbonate. Its pharmacological activity thus confers the risk for hypokalemia.
Withdrawn

7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide

Experimental

AL5300

Experimental
Displaying drugs 7176 - 7200 of 7847 in total